Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones

Go back to Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
(NYSE: RCUS) Delayed: 24.65 -1.5 (5.74%)
Previous Close $26.15    52 Week High
Open $26.50    52 Week Low
Day High $26.58    P/E N/A 
Day Low $24.32    EPS
Volume 3,555,873